record initialized not assigned to examiner
on 21 Jun 2024
Last Applicant/ Owned by
4105 Hopson Rd
Morrisville
NC
27560
Serial Number
98612779 filed on 21st Jun 2024
Registration Number
N/A
Correspondent Address
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
10th Floor
Washington, DC 20005
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, Read More
Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune-system-related diseases and disorders
N/A
N/A
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
N/A
N/A
Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing
N/A
N/A
No 98612779
No Service Mark
No 5525.0390000
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
21st Jun 2024 | NEW APPLICATION ENTERED |